Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Enrollment completed in phase III trial of Yondelis for relapsed ovarian cancer

June 21, 2007

Vegenics licenses antibodies against VEGF-C from CoGenesys

June 21, 2007

Nexavar submitted in E.U. for hepatocellular carcinoma

June 20, 2007

Ixabepilone NDA granted priority review

June 20, 2007

Telcyta clinical hold converted to partial hold

June 20, 2007

Genta to request review of Genasense's non-approvable status

June 20, 2007

NOV-002 slows disease progression in platinum-resistant ovarian cancer

June 20, 2007

Recent clinical data on nilotinib in leukemia presented

June 20, 2007

NicOx takes precautionary measures on NCX-4016 program

June 19, 2007

Apo2L/TRAIL in patients with advanced tumors

June 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...